Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 29, 2017

DrugPatentWatch Database Preview

CYTARABINE Drug Profile

« Back to Dashboard

Which patents cover Cytarabine, and what generic Cytarabine alternatives are available?

Cytarabine is a drug marketed by Fresenius Kabi Usa, Mylan Labs Ltd, Mylan Pharms Inc, Hospira, West-ward Pharms Int, and Teva Parenteral. and is included in thirteen NDAs.

The generic ingredient in CYTARABINE is cytarabine. There are fifteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the cytarabine profile page.

Summary for Tradename: CYTARABINE

Patents:0
Applicants:6
NDAs:13
Suppliers / Packagers: see list5
Bulk Api Vendors: see list73
Clinical Trials: see list445
Patent Applications: see list9,862
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:CYTARABINE at DailyMed

Pharmacology for Tradename: CYTARABINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa
CYTARABINE
cytarabine
INJECTABLE;INJECTION076512-001Jan 15, 2004APRXNoYes► Subscribe► Subscribe
West-ward Pharms Int
CYTARABINE
cytarabine
INJECTABLE;INJECTION074245-002Aug 31, 1994RXNoYes► Subscribe► Subscribe
Mylan Pharms Inc
CYTARABINE
cytarabine
INJECTABLE;INJECTION200916-001Dec 13, 2011APRXNoNo► Subscribe► Subscribe
Hospira
CYTARABINE
cytarabine
INJECTABLE;INJECTION075383-001Nov 22, 1999APRXNoNo► Subscribe► Subscribe
Hospira
CYTARABINE
cytarabine
INJECTABLE;INJECTION071868-001Jun 4, 1990APRXNoYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Identify first generic entrants

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot